NASDAQ

BridgeBio Oncology Therapeutics, Inc. (BBOT)

♥ 582 Thanks from members

Live price chart, market sentiment, and community perspectives for BridgeBio Oncology Therapeutics, Inc. (NASDAQ: BBOT).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: Oncology BiotechnologyFounder: BridgeBio PharmaLeadership: Neil Kumar (CEO)Holder: BridgeBio PharmaHolder: Institutional InvestorsOncology Pipeline Candidates#BBOT#BridgeBio Oncology#Precision Oncology#Biotech IPO#NASDAQ BBOT